MGRX (Mangoceuticals) Short-Term Capital Lease Obligation : $0.05 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Mangoceuticals Short-Term Capital Lease Obligation?

Mangoceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.05 Mil.

Mangoceuticals's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 ($0.07 Mil) to Dec. 2024 ($0.07 Mil) and declined from Dec. 2024 ($0.07 Mil) to Mar. 2025 ($0.05 Mil).

Mangoceuticals's annual Short-Term Capital Lease Obligation increased from Dec. 2022 ($0.06 Mil) to Dec. 2023 ($0.06 Mil) and increased from Dec. 2023 ($0.06 Mil) to Dec. 2024 ($0.07 Mil).

Mangoceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Mangoceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangoceuticals Short-Term Capital Lease Obligation Chart

Mangoceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

0.06

0.07

Mangoceuticals Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial									0.07	0.07	0.07	0.07	0.05

Mangoceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Mangoceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Mangoceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangoceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mangoceuticals Inc (NAS:MGRX) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

15110 N. Dallas Parkway, Suite 600, Dallas, TX, USA, 75248

Website

https://www.mangoceuticals.com

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Executives

Alex P. Hamilton	director	26 LOOP ROAD, BEDFORD NY 10506
Amanda Elizabeth Hammer	officer: Chief Operating Officer	5128 GADSDEN AVENUE, KELLER TX 76244
Jacob D. Cohen	director, 10 percent owner, officer: CEO	2101 GLENDALE DRIVE, PLANO TX 75023
Tiger Cub Trust	10 percent owner	19 RYDDINGTON PL, DALLAS TX 75230
Kenny Myers	director	5101 ADDISON CIRCLE,, UNIT 401,, ADDISON TX 75001
Lorraine Pamela D'alessio	director	8200 WILSHIRE BLVD, BEVERLY HILLS, CALIFORNIA CA 90211
Eugene M Johnston	officer: CFO	PO BOX 669047, CHARLOTTE NC 28266
Jonathan Arango	director, officer: President, COO and Secretary	15110 DALLAS PARKWAY, SUITE 600, DALLAS TX 75248